Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2F1 and telomerase: alliance in the dark side.

Marta M Alonso1, Juan Fueyo, W K Alfred Yung

  • 1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

Cell Cycle (Georgetown, Tex.)
|April 22, 2006
PubMed
Summary

The Rb/E2F1 pathway directly regulates telomerase activity, a key factor in cancer cell immortality. This link between E2F1 and human telomerase reverse transcriptase (hTERT) has clinical implications for glioblastoma prognosis and therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity.

Cancer cell·2026
Same author

Oncolytic adenoviral infection of chordoma achieves treatment efficacy associated with immunologic response and tumor microenvironmental alteration.

Neuro-oncology·2026
Same author

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Vaccines·2026
Same author

Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors.

Journal of neuro-oncology·2026
Same author

Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Microbial signals in primary and metastatic brain tumors.

Nature medicine·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer development involves genetic alterations, including Rb/E2F1 pathway deregulation and active telomerase, enabling cell immortality.
  • The Rb/E2F1 pathway and telomerase are crucial for cancer cell immortality and maintaining the neoplastic phenotype.

Purpose of the Study:

  • To review evidence linking the Rb/E2F1 pathway to telomerase activation.
  • To explore the clinical relevance of the E2F1-telomerase association in glioblastoma.

Main Methods:

  • Review of existing scientific literature and data.
  • Analysis of gene expression correlations in glioblastoma patient samples.

Main Results:

  • The Rb/E2F1 pathway directly modulates telomerase activity in normal and cancer cells.

Related Experiment Videos

  • Expression levels of E2F1 correlate with human telomerase reverse transcriptase (hTERT) in glioblastoma, indicating clinical relevance.

    • Conclusions:

    • A mechanistic link exists between E2F1 and telomerase activation.
    • This association offers prognostic significance and potential for novel therapeutic strategies in glioblastoma.